Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  BULGARIAN STOCK EXCHANGE  >  Sopharma Trading AD    SO5   BG1100086070

SOPHARMA TRADING AD (SO5)
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ( BGN)
Sales 2017 627 M
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 637 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,38x
Capi. / Sales2018 0,37x
Capitalization 236 M
More Financials
Company
Sopharma Trading AD engages in the wholesale and distribution of pharmaceutical, non-drugs and medical products.It offers logistic solutions for import, storage and distribution of pharmaceutical products as well as services on the appropriate positioning of the products on the hospital and... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on SOPHARMA TRADING AD
09/29 SOPHARMA TRADING : Jsc. reports 10% revenue growth in August, 2017
07/26 SOPHARMA TRADING : Jsc. reports growth of 11% in profit before taxes and 9% in r..
07/18 SOPHARMA TRADING : The Commission for Protection of Competition in Serbia has ap..
07/14 SOPHARMA TRADING : is the leader in Pharmaceutical sector in Capital Top 100 Ran..
02/28 SOPHARMA TRADING : Jsc. reports 5% growth in revenue from sales of goods in Janu..
01/25 SOPHARMA TRADING : Jsc. closes 2016 with 13% growth in the accumulated profit be..
2016 SOPHARMA TRADING : Jsc. reports 9% growth in revenue from sales of goods in Nove..
2016 SOPHARMA TRADING : Jsc. reports 118% growth in profit before taxes in October, 2..
2015 SOPHARMA TRADING AD SOFIA : Jsc. reports 5% growth of the profit before tax in A..
More news
Sector news : Generic Pharmaceuticals
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
More sector news : Generic Pharmaceuticals
Income Statement Evolution
Managers
NameTitle
Dimitar Georgiev Dimitrov Chief Executive Officer & Independent Director
Ognian Ivanov Donev Chairman
Dimitar Bogomilov Chief Financial Officer
Denitsa Georgieva Director-Technology & Business Solutions
Alexander Kaloferov Raychev Independent Director